Sam Emaminejad, assistant professor of electrical engineering at UCLA, has demonstrated that a wearable biosensor can be used in the diagnosis of cystic fibrosis, diabetes and other diseases.
UCLA biochemists have devised a way to convert sugar into a variety of useful chemical compounds without using cells and that could lead to the production of biofuels and pharmaceuticals.
The new technique can accurately identify a person’s optimal drug and dose combinations throughout an entire course of treatment, without complex, time-consuming genetic analysis.
Thyrosim can be used by clinicians, researchers and educators to gauge the impacts of thyroid treatments and to develop more effective remedies for thyroid problems.
UCLA awardees are Dino Di Carlo, a professor of bioengineering; Jonathan Hopkins, an assistant professor of mechanical and aerospace engineering; and Benjamin Williams, an associate professor of electrical engineering.
A new event created by the Ozcan Research Group of UCLA’s Henry Samueli School of Engineering and Applied Science showcased an impressive array of biomedical engineering technology research.